Buchumschlag

Response to the Letter to the Editor by Bett et al.

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury, Caroline M. Apovian, Angela Fitch, Jamy D. Ard, Zhaoping Li, Jesse Richards, W. Scott Butsch, Irina Jouravskaya, Kadie S. Vanderman, Lisa M. Neff
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Obesity
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Response to the Letter to the Editor by Athinarayanan
von: Jaime P. Almandoz, et al.
Veröffentlicht: (2024)

Nutritional considerations with antiobesity medications
von: Jaime P. Almandoz, et al.
Veröffentlicht: (2024)

The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
von: Shenelle A. Edwards‐Hampton, et al.
Veröffentlicht: (2024)

GLP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials
von: Kristen M. Beavers, et al.
Veröffentlicht: (2024)

Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
von: Jamy D. Ard, et al.
Veröffentlicht: (2024)

Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity
von: Jeffrey I. Mechanick, et al.
Veröffentlicht: (2024)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
von: Jamy D. Ard, et al.
Veröffentlicht: (2025)

Effect of Caloric Restriction on Predicted Risk of Incident Cardiovascular Disease and Type 2 Diabetes in Young Adults: Findings From the CALERIE 2 Trial
von: Ryan Chang, et al.
Veröffentlicht: (2026)

Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT ‐4
von: Theresa Hunter Gibble, et al.
Veröffentlicht: (2025)

Food insecurity and weight‐loss efforts among a nationally representative sample of US adults with higher weight
von: Kirstie M. Herb Neff
Veröffentlicht: (2024)

Response to “The safety of semaglutide in patients with depression and obesity”
von: Robert F. Kushner, et al.
Veröffentlicht: (2024)

Disparities in Prescription of Long‐Acting GLP‐1s
von: Katherine Wasden, et al.
Veröffentlicht: (2026)

Clarification of our response to “The importance of diversity in Obesity articles”
von: Michelle Cardel, et al.
Veröffentlicht: (2024)

Highway to the danger zone? A cautionary account that GLP‐1 receptor agonists may be too effective for unmonitored weight loss
von: Jesse R. Richards, et al.
Veröffentlicht: (2024)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
von: Faith Anne N. Heeren, et al.
Veröffentlicht: (2025)

Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
von: Lee M. Kaplan, et al.
Veröffentlicht: (2025)

New Horizons for the Ro Allison Indiana Dhurandhar Food Noise Inventory: Response to a Letter to the Editor
von: Misty A. W. Hawkins, et al.
Veröffentlicht: (2026)

Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE Study
von: Jamy Ard, et al.
Veröffentlicht: (2025)

Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program
von: Beverly G. Tchang, et al.
Veröffentlicht: (2025)

Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial
von: Peter T. Katzmarzyk, et al.
Veröffentlicht: (2026)

Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study
von: Kristina S. Boye, et al.
Veröffentlicht: (2025)

Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis
von: Ali Esparham, et al.
Veröffentlicht: (2024)

Association of Adverse Childhood Experiences and Metabolic Syndrome: A Systematic Review and Meta‐Analysis
von: Joohan Kim, et al.
Veröffentlicht: (2026)

The impact of lifestyle‐based weight loss in older adults with obesity on muscle and bone health: a balancing act
von: Tiffany M. Cortes, et al.
Veröffentlicht: (2025)

Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity
von: Meredith M. Hoog, et al.
Veröffentlicht: (2025)

Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
von: Hamlet Gasoyan, et al.
Veröffentlicht: (2025)

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT
von: Thomas A. Wadden, et al.
Veröffentlicht: (2026)

Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials
von: Domenica Rubino, et al.
Veröffentlicht: (2024)

Improving the diagnosis of hyperphagia in melanocortin‐4 receptor pathway diseases
von: M. Jennifer Abuzzahab, et al.
Veröffentlicht: (2025)

Letter to the Editor re “Cryolipolysis and Associated Health Outcomes, Adverse Events, and Satisfaction: A Systematic Review and Meta‐Analysis” Ravindran et al.
von: Nick Finer
Veröffentlicht: (2025)

Anthropometry for predicting cardiometabolic disease risk factors in adolescents
von: Luyu Xie, et al.
Veröffentlicht: (2024)

Sex differences in perceived discrimination among patients with obesity
von: Marianne O. Olaniran, et al.
Veröffentlicht: (2024)

Relationship Between Sleep Apnea Symptoms and Metabolic Syndrome Among Racially and Ethnically Diverse Adolescents and Young Adults in the United States
von: Deepali K. Ernest, et al.
Veröffentlicht: (2025)

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT ‐1 Over 176 Weeks
von: Hiddo J. L. Heerspink, et al.
Veröffentlicht: (2026)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
von: Sheila Pintado-Cucarella
Veröffentlicht: (2016)

Altered extracellular matrix dynamics is associated with insulin resistance in adolescent children with obesity
von: Aaron L. Slusher, et al.
Veröffentlicht: (2024)

Approach to weight management in patients with advanced chronic kidney disease in a real‐life clinical setting
von: Paola Lockhart Pastor, et al.
Veröffentlicht: (2024)

Clinical burden of hyperphagia, obesity and health outcomes in paediatric individuals with Bardet‐Biedl syndrome: A CRIBBS data analysis
von: Jeremy Pomeroy, et al.
Veröffentlicht: (2025)

Binge eating behaviours are associated with recurrent weight gain after metabolic and bariatric surgery
von: Matthew Cali, et al.
Veröffentlicht: (2025)

Comment From the Editor in Chief
von: Brian J. Oldfield
Veröffentlicht: (2026)